Geraldine N Tran1, Anand V Bodapati2, Jonathan C Routh3, Christopher S Saigal4, Hillary L Copp5. 1. School of Medicine, University of California-San Francisco, San Francisco, California. 2. Anderson School of Management, University of California-Los Angeles, Los Angeles, California. 3. Division of Urology, Duke University, Durham, North Carolina. 4. Department of Urology, University of California-Los Angeles, Los Angeles, California. 5. Department of Urology, University of California-San Francisco, San Francisco, California. Electronic address: hillary.copp@ucsf.edu.
Abstract
PURPOSE: Parents of children with vesicoureteral reflux are presented with a variety of management options, which in many cases offer a similar risk-benefit ratio. To facilitate shared decision making, parental preferences regarding vesicoureteral reflux treatment options need to be acknowledged. We aimed to characterize the clinical experience of parents and elicit core themes affecting decision making in regard to managing vesicoureteral reflux in their child. MATERIALS AND METHODS: A semistructured, qualitative interview script was developed and vetted by 25 pediatric urologists to discuss treatment options for vesicoureteral reflux. Additional patient interviews were conducted until new themes failed to arise. Content analysis was performed to extract all statements that described treatment options. Similar statements were combined until a final list of unique themes emerged. RESULTS: A total of 26 interviews were performed, yielding 689 statements about overall parent experiences with managing vesicoureteral reflux in the child and 450 statements (65%) pertaining to treatment options. Of the 13 themes that emerged, those most commonly considered were the prevention of future urinary tract infections by 85% of parents, the efficacy rate of treatment options by 85%, the burden of daily maintenance or compliance by 77%, antibiotic resistance by 69%, chronic kidney damage by 62% and invasiveness by 58%. CONCLUSIONS: Our study emphasizes that when choosing a treatment option for vesicoureteral reflux in their child, parent preferences regarding risks and benefits are variable. However, their chief concerns include whether a method decreases the risk of urinary tract infections, has an acceptable efficacy rate and aligns itself with the capabilities of the family. These themes help frame discussions between families and clinicians regarding vesicoureteral reflux management, and they can facilitate shared decision making.
PURPOSE: Parents of children with vesicoureteral reflux are presented with a variety of management options, which in many cases offer a similar risk-benefit ratio. To facilitate shared decision making, parental preferences regarding vesicoureteral reflux treatment options need to be acknowledged. We aimed to characterize the clinical experience of parents and elicit core themes affecting decision making in regard to managing vesicoureteral reflux in their child. MATERIALS AND METHODS: A semistructured, qualitative interview script was developed and vetted by 25 pediatric urologists to discuss treatment options for vesicoureteral reflux. Additional patient interviews were conducted until new themes failed to arise. Content analysis was performed to extract all statements that described treatment options. Similar statements were combined until a final list of unique themes emerged. RESULTS: A total of 26 interviews were performed, yielding 689 statements about overall parent experiences with managing vesicoureteral reflux in the child and 450 statements (65%) pertaining to treatment options. Of the 13 themes that emerged, those most commonly considered were the prevention of future urinary tract infections by 85% of parents, the efficacy rate of treatment options by 85%, the burden of daily maintenance or compliance by 77%, antibiotic resistance by 69%, chronic kidney damage by 62% and invasiveness by 58%. CONCLUSIONS: Our study emphasizes that when choosing a treatment option for vesicoureteral reflux in their child, parent preferences regarding risks and benefits are variable. However, their chief concerns include whether a method decreases the risk of urinary tract infections, has an acceptable efficacy rate and aligns itself with the capabilities of the family. These themes help frame discussions between families and clinicians regarding vesicoureteral reflux management, and they can facilitate shared decision making.
Authors: Michael H Hsieh; Ramiro J Madden-Fuentes; Aaron Bayne; Erika Munch; Patience Wildenfels; Sandra J Alexander; Edmond T Gonzales; Lars J Cisek; Eric A Jones; David R Roth Journal: J Urol Date: 2010-08-21 Impact factor: 7.450
Authors: Aaron J Krill; Hans G Pohl; A Barry Belman; Steven J Skoog; Warren T Snodgrass; H Gil Rushton Journal: J Urol Date: 2011-09-23 Impact factor: 7.450
Authors: Craig A Peters; Steven J Skoog; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz Journal: J Urol Date: 2010-07-21 Impact factor: 7.450
Authors: Nancy K Janz; Patricia A Wren; Laurel A Copeland; Julie C Lowery; Sherry L Goldfarb; Edwin G Wilkins Journal: J Clin Oncol Date: 2004-08-01 Impact factor: 44.544
Authors: Zachary R Dionise; Juan Marcos Gonzalez; Michael L Garcia-Roig; Andrew J Kirsch; Charles D Scales; John S Wiener; J Todd Purves; Jonathan C Routh Journal: Urology Date: 2019-03-14 Impact factor: 2.649